These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 15673801

  • 1. Etanercept plus standard therapy for Wegener's granulomatosis.
    Wegener's Granulomatosis Etanercept Trial (WGET) Research Group.
    N Engl J Med; 2005 Jan 27; 352(4):351-61. PubMed ID: 15673801
    [Abstract] [Full Text] [Related]

  • 2. Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety.
    Stone JH, Uhlfelder ML, Hellmann DB, Crook S, Bedocs NM, Hoffman GS.
    Arthritis Rheum; 2001 May 27; 44(5):1149-54. PubMed ID: 11352248
    [Abstract] [Full Text] [Related]

  • 3. Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial.
    Stone JH, Holbrook JT, Marriott MA, Tibbs AK, Sejismundo LP, Min YI, Specks U, Merkel PA, Spiera R, Davis JC, St Clair EW, McCune WJ, Ytterberg SR, Allen NB, Hoffman GS, Wegener's Granulomatosis Etanercept Trial Research Group.
    Arthritis Rheum; 2006 May 27; 54(5):1608-18. PubMed ID: 16646004
    [Abstract] [Full Text] [Related]

  • 4. Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).
    Seo P, Min YI, Holbrook JT, Hoffman GS, Merkel PA, Spiera R, Davis JC, Ytterberg SR, St Clair EW, McCune WJ, Specks U, Allen NB, Luqmani RA, Stone JH, WGET Research Group.
    Arthritis Rheum; 2005 Jul 27; 52(7):2168-78. PubMed ID: 15986348
    [Abstract] [Full Text] [Related]

  • 5. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
    Pagnoux C, Mahr A, Hamidou MA, Boffa JJ, Ruivard M, Ducroix JP, Kyndt X, Lifermann F, Papo T, Lambert M, Le Noach J, Khellaf M, Merrien D, Puéchal X, Vinzio S, Cohen P, Mouthon L, Cordier JF, Guillevin L, French Vasculitis Study Group.
    N Engl J Med; 2008 Dec 25; 359(26):2790-803. PubMed ID: 19109574
    [Abstract] [Full Text] [Related]

  • 6. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group.
    Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG.
    N Engl J Med; 1996 Jul 04; 335(1):16-20. PubMed ID: 8637536
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.
    Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ.
    N Engl J Med; 1999 Jan 28; 340(4):253-9. PubMed ID: 9920948
    [Abstract] [Full Text] [Related]

  • 9. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial.
    Stone JH, Wegener's Granulomatosis Etanercept Trial Research Group.
    Arthritis Rheum; 2003 Aug 28; 48(8):2299-309. PubMed ID: 12905485
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate.
    Reinhold-Keller E, Fink CO, Herlyn K, Gross WL, De Groot K.
    Arthritis Rheum; 2002 Jun 15; 47(3):326-32. PubMed ID: 12115164
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
    Tervaert JW, Stegeman CA.
    Ned Tijdschr Geneeskd; 2003 Nov 15; 147(46):2265-7. PubMed ID: 14655291
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Herpes zoster in immunocompromised patients: incidence, timing, and risk factors.
    Wung PK, Holbrook JT, Hoffman GS, Tibbs AK, Specks U, Min YI, Merkel PA, Spiera R, Davis JC, St Clair EW, McCune J, Ytterberg SR, Allen NB, Stone JH, WGET Research Group.
    Am J Med; 2005 Dec 15; 118(12):1416. PubMed ID: 16378799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.